Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Diabetes Mellitus, Type 2”

11,928 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 11,928 results

Large-scale testing (Phase 3)Study completedNCT04504396
What this trial is testing

Safety and Efficacy of PB-119 in Subjects With Type 2 Diabetes and Not Well-controlled by Metformin Monotherapy

Who this might be right for
Type 2 Diabetes Mellitus (T2DM)
PegBio Co., Ltd. 620
Not applicableStudy completedNCT00923962
What this trial is testing

Endothelial and Metabolic Effects of Glucagon-like Peptide-1 (GLP-1) in Coronary Circulation in Patients With Type 2 Diabetes Mellitus

Who this might be right for
Type 2 Diabetes Mellitus
University Hospital, Gentofte, Copenhagen 35
Not applicableEnrolling By InvitationNCT06831162
What this trial is testing

Evaluating the Effectiveness of a Multi-level Health-Related Social Needs Initiative

Who this might be right for
Type 2 DiabetesHypertensionHyperlipidemia+1 more
Vanderbilt University Medical Center 4,809
Early research (Phase 1)Study completedNCT07691203
What this trial is testing

Bioequivalence Study to Compare Empagliflozin/Linagliptin/Metformin HCl 25 mg/5 mg/1000 mg Extended Release Tablet Versus Trijardy® XR 25 mg/5 mg/1000 mg Extended- Release Tablets

Who this might be right for
Type 2 Diabetes Mellitus (T2DM)Cardiovascular Diseases
Humanis Saglık Anonim Sirketi 36
Early research (Phase 1)Study completedNCT01272973
What this trial is testing

Investigation on Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of NN9924 in Healthy Male Subjects

Who this might be right for
DiabetesDiabetes Mellitus, Type 2Healthy
Novo Nordisk A/S 96
Early research (Phase 1)Study completedNCT07242469
What this trial is testing

A Clinical Trial of MK-1403 in Participants With Type 2 Diabetes Mellitus (MK-1403-006)

Who this might be right for
Diabetes Mellitus, Type 2
Merck Sharp & Dohme LLC 53
Post-approval studies (Phase 4)Study completedNCT01907854
What this trial is testing

Efficacy and Safety of Switching From Sitagliptin to Liraglutide in Subjects With Type 2 Diabetes Not Achieving Adequate Glycaemic Control on Sitagliptin and Metformin

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 407
Not applicableNot Yet RecruitingNCT07695454
What this trial is testing

Imaging in Semaglutide Study

Who this might be right for
Type 2 DiabetesBMI Greater Than 30
The Cleveland Clinic 10
Large-scale testing (Phase 3)Study completedNCT00480805
What this trial is testing

HYZAAR vs. Ramipril for Diabetes (0954A-245)(COMPLETED)

Who this might be right for
Type 2 Diabetes MellitusHypertension
Organon and Co 312
Not applicableStudy completedNCT01518205
What this trial is testing

HELP-Apheresis in Diabetic Ischemic Foot Treatment (H.A.D.I.F)

Who this might be right for
Foot UlcersArteriosclerosis ObliteransDiabetes Mellitus
Universita di Verona 13
Early research (Phase 1)Study completedNCT03376802
What this trial is testing

A Clinical Study to Investigate the Effect of SAR425899 on Energy Expenditure in Obese Subjects

Who this might be right for
Type 2 Diabetes Mellitus
Sanofi 24
Post-approval studies (Phase 4)Study completedNCT05624853
What this trial is testing

A Randomized, Active-controlled, Parallel, Open-label, Multicenter, Phase 4 Study to Compare the Efficacy and Safety of Pregabalin Sustained Release Tablet and Pregabalin Immediate Release Capsule in Type II Diabetic Patients With Peripheral Neuropathic Pain

Who this might be right for
Neuropathic PainDiabetes Mellitus, Type 2
Yuhan Corporation 130
Post-approval studies (Phase 4)UnknownNCT05870462
What this trial is testing

Semaglutide and Vascular Regeneration

Who this might be right for
AtherosclerosisCardiovascular DiseasesDiabetes Mellitus, Type 2+1 more
Canadian Medical and Surgical Knowledge Translation Research Group 100
Not applicableStudy completedNCT04499846
What this trial is testing

Educational Intervention Targeting Statin Therapy and Compliance in Diabetic Patients

Who this might be right for
Type II Diabetes
Lille Catholic University 96
Not applicableStudy completedNCT04114903
What this trial is testing

Exploring the Anti-inflammatory Properties of Cannabis and Their Relevance to Insulin Sensitivity

Who this might be right for
Type 2 DiabetesObesityCannabis Use+1 more
University of Colorado, Boulder 233
Early research (Phase 1)Study completedNCT00552227
What this trial is testing

Isoprostane/FMD Study The Effect of Protein Kinase C (PKC) β Specific Inhibitor LY333531 on Oxidant Stress in Patients With Type 2 Diabetes Mellitus

Who this might be right for
Diabetes Mellitus
Chromaderm, Inc. 48
Testing effectiveness (Phase 2)UnknownNCT05234086
What this trial is testing

Cell Therapy for Diabetic Foot Ulcer

Who this might be right for
Diabetic Foot Ulcer Associated With Type II Diabetes MellitusWound Heal
Instituto para el Desarrollo Biotecnológico y la Innovación S.A. 60
Post-approval studies (Phase 4)Active Not RecruitingNCT06860841
What this trial is testing

Effects of D-Chiro-Inositol Combined with Metformin on Insulin Resistance in People with Overweight or Obesity and T2DM

Who this might be right for
Type 2 DiabetesOverweight and Obese Adults
Campus Bio-Medico University 16
Not applicableStudy completedNCT01806194
What this trial is testing

Empowering Rural African American Women and Communities to Improve Diabetes Outcomes

Who this might be right for
Type 2 Diabetes Mellitus
East Carolina University 200
Not applicableStudy completedNCT01935466
What this trial is testing

Risk of Bladder Cancer in Type 2 Diabetes Patients With Pioglitazone Therapy "PROBE"

Who this might be right for
Bladder Cancer
Post Graduate Institute of Medical Education and Research, Chandigarh 6,107
Next Page